scholarly journals The modern ideas about the etiology of irritable bowel syndrome

2019 ◽  
pp. 152-155 ◽  
Author(s):  
G. M. Sakhautdinova ◽  
R. R. Nagaeva ◽  
K. E. Asanbaeva

This article is devoted to the theme of the etiology of irritable bowel syndrome. This topic is highlighted in comparison with the Roman diagnostic criteria of III and IV revision. The following is considered: the theory of disturbed interaction within the «brain-gut» axis and visceral hypersensitivity induced in this way, as well as a possible mechanism for its implementation; also, the relationship of symptoms of IBS with patients’ mental state: anxiety, depression, sleep disorders. The relationship of IBS with microbiota of the intestine, the genetic mediation of IBS, the examples of candidate genes in biomarkers; the mechanisms of work of these genes are also described; the issue of intolerance to certain foods (FODMAPs, IgE-mediated hypersensitivity) in patients with IBS is highlighted as well; immunological aspects, including the theory of subclinical inflammation (low-grade inflammation) or post-infection IBS.

2016 ◽  
Vol 7 (1) ◽  
Author(s):  
Osama Hasan Gaber

<p>This study aimed to examine the relationship of irritable bowel syndrome, anxiety, depression and stress among a sample of78 IBS patients (Rome III Diagnostic Criteria for Irritable Bowel Syndrome),anxiety symptoms scale ,Depression symptoms scale ,and stress scale (prepared by the researcher) were used Pearson Correlation Coefficient showed that there are statistically significant relationship between IBS and Anxiety ,Depression and Stress (P≤=0.01).The Regression and Prediction Coefficient (stepwise) was also used and showed that the depression and Stress of predicts to IBS.<strong></strong></p>


2004 ◽  
Vol 18 (10) ◽  
pp. 601-603 ◽  
Author(s):  
Christopher N Andrews ◽  
Eldon A Shaffer

Not so long ago, physicians construed the irritable bowel syndrome (IBS) as being a neurotic trait: it was all in the head. Today most clinicians believe that the main abnormality lies in the brain (and spinal cord), which reacts abnormally to stimuli from the gut. Recent studies are identifying a basis for these neural changes - low grade inflammation in the gut - which may play a key role in IBS.


2017 ◽  
Vol 23 (36) ◽  
pp. 6593-6627 ◽  
Author(s):  
Emanuele Sinagra ◽  
Gaetano Cristian Morreale ◽  
Ghazaleh Mohammadian ◽  
Giorgio Fusco ◽  
Valentina Guarnotta ◽  
...  

2021 ◽  
Author(s):  
Yang Liu ◽  
Wei Xiao ◽  
Leilei Yu ◽  
Fengwei Tian ◽  
Gang Wang ◽  
...  

Irritable bowel syndrome (IBS) is a chronic intestinal disorder accompanied by low-grade inflammation, visceral hypersensitivity, and gut microbiota dysbiosis. Several studies have indicated that Lactobacillus supplementation can help to alleviate...


1996 ◽  
Vol 8 (2) ◽  
pp. 81-88 ◽  
Author(s):  
David Kaplan ◽  
Prakash Masand ◽  
Sanjay Gupta

2011 ◽  
Vol 140 (5) ◽  
pp. S-364
Author(s):  
Gregory S. Sayuk ◽  
Christina L. Fales ◽  
C. Prakash Gyawali ◽  
Billy D. Nix ◽  
Yvette I. Sheline

2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Song Jizhong ◽  
Wang Qiaomin ◽  
Wang Chao ◽  
Li Yanqing

The mechanism of low-grade inflammation in irritable bowel syndrome (IBS) is unclear; our research concentrates on the involvement of the corticotropin-releasing factor (CRF) and Toll-like receptor (TLR) gene expression in the process of low-grade inflammation in IBS patients with depression. This study suggests more IBS patients are presenting with the states of depression and anxiety. IBS patients with depression have shown a lower grade inflammatory response and an imbalance of the inflammatory response. CRF1, CRF2, TLR2, and TLR4 in IBS patients with depression are significantly higher than those without depression and controls. Thus, activation of the CRF-TLR associated pathways produces an inflammatory reaction, which can concurrently affect the digestive tract and the CNS and induce the corresponding digestive and psychiatric symptoms.


2016 ◽  
Vol 22 (46) ◽  
pp. 10198 ◽  
Author(s):  
Anna Chiara Piscaglia ◽  
Lucrezia Laterza ◽  
Valentina Cesario ◽  
Viviana Gerardi ◽  
Rosario Landi ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-13 ◽  
Author(s):  
Uday C. Ghoshal ◽  
Ratnakar Shukla ◽  
Ujjala Ghoshal ◽  
Kok-Ann Gwee ◽  
Siew C. Ng ◽  
...  

Progress in the understanding of the pathophysiology of irritable bowel syndrome (IBS), once thought to be a purely psychosomatic disease, has advanced considerably and low-grade inflammation and changes in the gut microbiota now feature as potentially important. The human gut harbours a huge microbial ecosystem, which is equipped to perform a variety of functions such as digestion of food, metabolism of drugs, detoxification of toxic compounds, production of essential vitamins, prevention of attachment of pathogenic bacteria to the gut wall, and maintenance of homeostasis in the gastrointestinal tract. A subset of patients with IBS may have a quantitative increase in bacteria in the small bowel (small intestinal bacterial overgrowth). Qualitative changes in gut microbiota have also been associated with IBS. Targeting the gut microbiota using probiotics and antibiotics has emerged as a potentially effective approach to the treatment of this, hitherto enigmatic, functional bowel disorder. The gut microbiota in health, quantitative and qualitative microbiota changes, and therapeutic manipulations targeting the microbiota in patients with IBS are reviewed in this paper.


Sign in / Sign up

Export Citation Format

Share Document